Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application

Choroidal neovascularization (CNV) secondary to pathologic myopia has a very high incidence in global, especially in Asian, populations. It is a common cause of irreversible central vision loss, and severely affects the quality of life in the patients with pathologic myopia. The traditional therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Han, Qian, Ru, Yusha, Bo, Qiyu, Wei, Rui Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494177/
https://www.ncbi.nlm.nih.gov/pubmed/26170626
http://dx.doi.org/10.2147/DDDT.S87920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494177/
https://www.ncbi.nlm.nih.gov/pubmed/26170626
http://dx.doi.org/10.2147/DDDT.S87920

Ejemplares similares